Free Trial
→ Uranium Mine Flood That Sparked a 2006 Price Surge Returns (From Digest Publishing) (Ad)tc pixel Free HRTX Stock Alerts

Heron Therapeutics (HRTX) Earnings Date, Estimates & Call Transcripts

Heron Therapeutics logo
$0.37 +0.00 (+0.94%)
Closing price 11/10/2026 04:00 PM Eastern
Extended Trading
$0.36 -0.01 (-3.77%)
As of 05:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Heron Therapeutics Earnings Summary

Heron Therapeutics posted Q3 2026 earnings on November 9, 2026, reporting an EPS of -$0.03, which hit the consensus estimate of -$0.03. Quarterly revenue was reported to be $35.25 million, below the consensus estimate of $37.50 million. With a trailing EPS of -$0.19, Heron Therapeutics' earnings are expected to grow next year, from ($0.14) to ($0.12) per share.

Latest Q3
Earnings Date
Nov. 9Estimated
Consensus EPS
(Nov. 9)
-$0.03
Actual EPS
(Nov. 9)
-$0.03
Actual Revenue
(Nov. 9)
$35.25M

Q3 2026 Earnings Resources

Powered by Quartr
Get Heron Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Heron Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

HRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Heron Therapeutics Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Revenue GuidanceRevenue Estimate at Guidance
Q1 20262-$0.04-$0.02-$0.03
Q2 20262-$0.02-$0.01-$0.02
Q3 20262-$0.03$0.00-$0.02
Q4 20262-$0.03$0.01-$0.01
FY 20268-$0.12-$0.02-$0.07

Heron Therapeutics Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026-$0.03-$0.03--$0.03$37.50M$35.25M
8/10/2026Q2 2026-$0.0050-$0.03 -$0.0250-$0.03$42.19M$37.67M
5/11/2026Q1 2026-$0.03-$0.04 -$0.01-$0.04$36.72M$34.71M
2/26/2026Q4 2025-$0.03-$0.02+$0.01-$0.02$39.53M$40.59M
11/4/2025Q3 2025-$0.02-$0.05 -$0.03-$0.10$39.03M$38.21M
8/8/2025Q2 2025-$0.01-$0.02 -$0.01-$0.02$38.08M$37.20M
5/6/2025Q1 2025-$0.01$0.01+$0.02$0.01$37.08M$38.90M
2/27/2025Q4 2024-$0.03$0.02+$0.05$0.02$37.37M$40.78M
11/12/2024Q3 2024-$0.03-$0.03--$0.03$36.40M$32.81M

Heron Therapeutics Earnings - Frequently Asked Questions

Heron Therapeutics (NASDAQ:HRTX) last announced its quarterly earning data on Monday, November 9, 2026. Learn more on HRTX's earnings history.

In the previous quarter, Heron Therapeutics (NASDAQ:HRTX) reported ($0.03) earnings per share (EPS) to hit the analysts' consensus estimate of ($0.03). Learn more on analysts' earnings estimate vs. HRTX's actual earnings.

Heron Therapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

Heron Therapeutics (NASDAQ:HRTX) has a recorded annual revenue of $154.90 million.

Heron Therapeutics (NASDAQ:HRTX) has a recorded net income of -$20.19 million. HRTX has generated -$0.19 earnings per share over the last four quarters.

Heron Therapeutics' earnings are expected to grow from ($0.14) per share to ($0.12) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:HRTX is sourced from Fiscal.ai, with the most recent quarter reported on 11/9/2026. New results are added as companies report their earnings.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Trump’s EO to send this $5 stock ripping higher…?
President Trump's December executive order declared space a national security and economic priority, fueling a...
Traders Agency | Sponsoredtc pixel
Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...
Weiss Ratings | Sponsoredtc pixel
My prediction for December 8th
Elon doesn't own the chip inside his Teslas or Starlink dishes. He licenses it from one little known public co...
Behind the Markets | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Your Copy is Available to Claim
James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...
Paradigm Press | Sponsoredtc pixel
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...
Digest Publishing | Sponsoredtc pixel